Anixa Biosciences Inc (ANIX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $91.08M
Last updated: Nov 17, 2026 at 11:04 AM ET
Anixa Biosciences Inc (ANIX) Earnings: Report Dates and Results
Anixa Biosciences (ANIX) is expected to report earnings on Jan 11, 2027. In the quarter ended Jul 31, 2026, Anixa Biosciences reported EPS of -$0.08, in line with the -$0.08 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
ANIX has an expected report date of Jan 11, 2027.
Earnings History
Of the 33 quarters below that had an estimate, ANIX beat 21, missed 6 and matched 6. The widest gap in the table came in the quarter ended Jul 31, 2021, when EPS landed 75.00% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | -$0.08 | -$0.08 | -$0.08 - -$0.08 | 0.00% | In line | N/A | 1 | 1 up, 0 down | Sep 9, 2026 | N/A |
| Apr 30, 2026 | -$0.07 | -$0.10 | -$0.10 - -$0.10 | +30.00% | Beat | N/A | 1 | 0 up, 0 down | Jun 10, 2026 | N/A |
| Jan 31, 2026 | -$0.08 | -$0.09 | -$0.10 - -$0.08 | +11.11% | Beat | N/A | 2 | 0 up, 0 down | Mar 9, 2026 | N/A |
| Oct 31, 2025 | -$0.08 | -$0.08 | N/A | +3.96% | Beat | N/A | 1 | 1 up, 0 down | Jan 12, 2026 | N/A |
| Jul 31, 2025 | -$0.07 | -$0.10 | -$0.10 - -$0.10 | +30.00% | Beat | N/A | 1 | 1 up, 0 down | Sep 10, 2025 | N/A |
| Apr 30, 2025 | -$0.09 | -$0.10 | -$0.10 - -$0.10 | +10.00% | Beat | N/A | 1 | 1 up, 0 down | May 28, 2025 | N/A |
| Jan 31, 2025 | -$0.10 | -$0.10 | -$0.10 - -$0.10 | 0.00% | In line | N/A | 1 | 1 up, 0 down | Mar 11, 2025 | N/A |
| Oct 31, 2024 | -$0.09 | -$0.11 | -$0.11 - -$0.11 | +18.18% | Beat | N/A | 1 | 0 up, 1 down | Jan 10, 2025 | N/A |
| Jul 31, 2024 | -$0.10 | -$0.11 | -$0.11 - -$0.08 | +9.09% | Beat | N/A | 2 | 0 up, 0 down | Sep 6, 2024 | N/A |
| Apr 30, 2024 | -$0.10 | -$0.11 | -$0.11 - -$0.11 | +9.09% | Beat | N/A | 1 | 0 up, 0 down | Jun 4, 2024 | N/A |
| Jan 31, 2024 | -$0.10 | -$0.09 | -$0.09 - -$0.09 | -11.11% | Miss | N/A | 1 | 0 up, 0 down | Mar 12, 2024 | N/A |
| Oct 31, 2023 | -$0.09 | -$0.09 | N/A | 0.00% | In line | N/A | N/A | 0 up, 0 down | Jan 16, 2024 | $156000 |
| Jul 31, 2023 | -$0.08 | -$0.09 | -$0.09 - -$0.09 | +11.11% | Beat | N/A | 1 | 0 up, 0 down | Sep 6, 2023 | N/A |
| Apr 30, 2023 | -$0.07 | -$0.11 | -$0.12 - -$0.11 | +36.36% | Beat | N/A | 2 | 0 up, 0 down | Jun 14, 2023 | $210000 |
| Jan 31, 2023 | -$0.08 | -$0.16 | -$0.16 - -$0.16 | +50.00% | Beat | N/A | 1 | 0 up, 0 down | Mar 16, 2023 | N/A |
| Oct 31, 2022 | -$0.12 | -$0.11 | -$0.13 - -$0.09 | -9.09% | Miss | N/A | 2 | 0 up, 0 down | Jan 4, 2023 | $2.47B |
| Jul 31, 2022 | -$0.09 | -$0.13 | -$0.13 - -$0.13 | +30.77% | Beat | N/A | 1 | 0 up, 0 down | Sep 9, 2022 | N/A |
| Apr 30, 2022 | -$0.12 | -$0.13 | -$0.13 - -$0.13 | +7.69% | Beat | N/A | 1 | 0 up, 0 down | Jun 10, 2022 | N/A |
| Jan 31, 2022 | -$0.13 | -$0.13 | -$0.13 - -$0.13 | 0.00% | In line | N/A | 1 | 0 up, 0 down | Mar 11, 2022 | N/A |
| Oct 31, 2021 | -$0.13 | -$0.09 | -$0.09 - -$0.09 | -44.44% | Miss | N/A | 1 | 0 up, 0 down | Jan 4, 2022 | $3.61M |
| Jul 31, 2021 | -$0.14 | -$0.08 | -$0.08 - -$0.08 | -75.00% | Miss | N/A | 1 | N/A | Sep 1, 2021 | N/A |
| Apr 30, 2021 | -$0.08 | -$0.10 | -$0.12 - -$0.09 | +20.00% | Beat | N/A | 2 | N/A | Jun 10, 2021 | N/A |
| Jan 31, 2021 | -$0.07 | -$0.11 | -$0.11 - -$0.11 | +36.36% | Beat | N/A | 1 | N/A | Mar 11, 2021 | $513000 |
| Oct 31, 2020 | -$0.09 | -$0.10 | -$0.11 - -$0.10 | +10.00% | Beat | N/A | 2 | N/A | Jan 7, 2021 | N/A |
| Jul 31, 2020 | -$0.11 | -$0.12 | -$0.13 - -$0.12 | +8.33% | Beat | N/A | 2 | N/A | Sep 8, 2020 | N/A |
| Apr 30, 2020 | -$0.12 | -$0.13 | -$0.13 - -$0.12 | +7.69% | Beat | N/A | 2 | N/A | Jun 9, 2020 | N/A |
| Jan 31, 2020 | -$0.13 | -$0.13 | -$0.13 - -$0.13 | 0.00% | In line | N/A | 1 | N/A | Mar 9, 2020 | N/A |
| Oct 31, 2019 | -$0.10 | -$0.24 | -$0.24 - -$0.24 | +58.33% | Beat | N/A | 1 | N/A | Jan 9, 2020 | N/A |
| Jul 31, 2019 | -$0.11 | -$0.23 | -$0.23 - -$0.23 | +52.17% | Beat | N/A | 1 | N/A | Sep 6, 2019 | N/A |
| Apr 30, 2019 | -$0.13 | -$0.23 | -$0.23 - -$0.23 | +43.48% | Beat | N/A | 1 | N/A | Jun 11, 2019 | $250000 |
| Jan 31, 2019 | -$0.23 | -$0.15 | -$0.15 - -$0.15 | -53.33% | Miss | N/A | 1 | N/A | Mar 13, 2019 | N/A |
| Oct 31, 2018 | -$0.26 | -$0.15 | -$0.15 - -$0.15 | -73.33% | Miss | N/A | 1 | N/A | Jan 11, 2019 | N/A |
| Jul 31, 2018 | -$0.30 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 7, 2018 | $362500 |
| Apr 30, 2018 | -$0.08 | N/A | N/A | N/A | N/A | -500.0% | N/A | N/A | Jun 11, 2018 | $750000 |
| Jan 31, 2018 | -$0.11 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 9, 2018 | N/A |
| Oct 31, 2017 | -$0.12 | -$0.12 | N/A | 0.00% | In line | N/A | N/A | N/A | Jan 9, 2018 | N/A |
| Jul 31, 2017 | -$0.12 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 8, 2017 | $362500 |
| Apr 30, 2017 | $0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 26, 2017 | N/A |
| Jan 31, 2017 | -$0.41 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 16, 2017 | N/A |
| Oct 31, 2016 | -$0.12 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 7, 2016 | $200000 |
Annual EPS
EPS for the fiscal year ended Oct 31, 2025 was -$0.34, after -$0.39 the year before. It was -$0.57 for the year ended Oct 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Oct 31, 2025 | -$0.34 | N/A |
| Oct 31, 2024 | -$0.39 | N/A |
| Oct 31, 2023 | -$0.32 | N/A |
| Oct 31, 2022 | -$0.46 | N/A |
| Oct 31, 2021 | -$0.42 | N/A |
| Oct 31, 2020 | -$0.45 | N/A |
| Oct 31, 2019 | -$0.57 | N/A |
| Oct 31, 2018 | -$0.75 | N/A |
| Oct 31, 2017 | -$0.63 | N/A |
| Oct 31, 2016 | -$0.57 | N/A |
Frequently Asked Questions About ANIX
When is Anixa Biosciences's next earnings date?
Anixa Biosciences's next earnings report is expected for Jan 11, 2027.
Did ANIX beat earnings estimates last quarter?
Anixa Biosciences reported EPS of -$0.08 for the quarter ended Jul 31, 2026, in line with the -$0.08 estimate.
What EPS do analysts expect from ANIX next quarter?
The consensus EPS estimate for Anixa Biosciences for the quarter ended Oct 31, 2026 is -$0.08 from 5 analysts, with estimates from -$0.09 to -$0.08.
How often does ANIX beat earnings estimates?
Anixa Biosciences beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +12.91%.
ANIX pages: Overview, Earnings, Forecast, Financials, Competitors